A. Fujii

Deoxyspergualin, a novel immunosuppressant, markedly inhibits human mixed lymphocyte reaction and cytotoxic T-lymphocyte activity in vitro.

J. Talmadge, F. Abe, T. Takeuchi, 1992, International journal of immunopharmacology.

Deoxyspergualin directly suppresses antibody formation in vivo and in vitro.

F. Abe, T. Takeuchi, T. Takada, 1990, The Journal of antibiotics.

Deoxyspergualin in lethal murine graft-versus-host disease.

F. Abe, T. Takeuchi, M. Hayashi, 1991, Transplantation.

In vitro immunosuppressive properties of spergualins to murine T cell response.

F. Abe, T. Takeuchi, T. Takada, 1989, The Journal of antibiotics.

The study of cytopathological aspects induced by human cytomegalovirus infection

T. Ishikawa, H. Takeuchi, T. Okumiya, 2004, Diagnostic cytopathology.

Therapeutic activity of deoxyspergualin in comparison with cyclosporin A, and its combined use with cyclosporin A and prednisolone in highly allogeneic skin transplantation in the rat.

F. Abe, T. Takeuchi, M. Hayashi, 1992, Agents and actions.